How much did Paion achieve in EBIT for the current year?
In the current year, Paion has achieved an EBIT of -12.07 M EUR.
Paion EBIT 2024
Paion EBIT
-12.07 M EUR
Ticker
PA8.DE
ISIN
DE000A0B65S3
WKN
A0B65S
In 2024, Paion's EBIT was -12.07 M EUR, a -20.07% increase from the -15.1 M EUR EBIT recorded in the previous year.
The Paion EBIT history
| YEAR | EBIT (undefined EUR) |
|---|---|
| 2028e | - |
| 2027e | 15.78 |
| 2026e | 8.25 |
| 2025e | -1.77 |
| 2024e | -12.07 |
| 2023e | -15.1 |
| 2022 | 1.51 |
| 2021 | -22.08 |
| 2020 | 1.58 |
| 2019 | -9.36 |
| 2018 | -12.39 |
| 2017 | -15.84 |
| 2016 | -25.08 |
| 2015 | -35 |
| 2014 | -12.04 |
| 2013 | -2.81 |
| 2012 | 18.87 |
| 2011 | -13.36 |
| 2010 | -9.03 |
| 2009 | -13 |
| 2008 | -13.8 |
| 2007 | -12.63 |
| 2006 | -18.78 |
| 2005 | -5.81 |
| 2004 | -0.09 |
| 2003 | -11.01 |
Paion Revenue, EBIT, Net Income DE000A0B65S3 · A0B65S
3 years
5 years
10 years
25 Years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into Paion, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Paion from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Paion’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of Paion. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into Paion’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing Paion’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Paion’s growth potential.
Paion Revenue, EBIT and net profit per share
| Date | Paion Revenue | Paion EBIT | Paion Net Income |
|---|---|---|---|
| 2028e | 135.79 M undefined | 0 undefined | 0 undefined |
| 2027e | 95.32 M undefined | 15.78 M undefined | 0 undefined |
| 2026e | 48.16 M undefined | 8.25 M undefined | 1.24 M undefined |
| 2025e | 36.56 M undefined | -1.77 M undefined | -4.61 M undefined |
| 2024e | 20.4 M undefined | -12.07 M undefined | -14.3 M undefined |
| 2023e | 13.69 M undefined | -15.1 M undefined | -16.28 M undefined |
| 2022 | 33.25 M undefined | 1.51 M undefined | -579,000 undefined |
| 2021 | 7.13 M undefined | -22.08 M undefined | -21.79 M undefined |
| 2020 | 19.66 M undefined | 1.58 M undefined | 2.22 M undefined |
| 2019 | 8 M undefined | -9.36 M undefined | -7.02 M undefined |
| 2018 | 2.77 M undefined | -12.39 M undefined | -9.94 M undefined |
| 2017 | 5.81 M undefined | -15.84 M undefined | -12.09 M undefined |
| 2016 | 4.26 M undefined | -25.08 M undefined | -20.12 M undefined |
| 2015 | 71,610 undefined | -35 M undefined | -28.21 M undefined |
| 2014 | 3.46 M undefined | -12.04 M undefined | -9.1 M undefined |
| 2013 | 4.23 M undefined | -2.81 M undefined | -2.21 M undefined |
| 2012 | 26.81 M undefined | 18.87 M undefined | 16.01 M undefined |
| 2011 | 3.25 M undefined | -13.36 M undefined | -13.68 M undefined |
| 2010 | 4.47 M undefined | -9.03 M undefined | -9.25 M undefined |
| 2009 | 1.53 M undefined | -13 M undefined | -13.04 M undefined |
| 2008 | 3.17 M undefined | -13.8 M undefined | -12.58 M undefined |
| 2007 | 4.85 M undefined | -12.63 M undefined | -10.51 M undefined |
| 2006 | 10.46 M undefined | -18.78 M undefined | -17.39 M undefined |
| 2005 | 18.8 M undefined | -5.81 M undefined | -4.76 M undefined |
| 2004 | 16.95 M undefined | -90,000 undefined | 180,000 undefined |
| 2003 | 710,000 undefined | -11.01 M undefined | -10.86 M undefined |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2003 | 710,000 EUR | -11.01 M EUR | -10.86 M EUR |
| 2004 | 16.95 M EUR | -90,000 EUR | 180,000 EUR |
| 2005 | 18.8 M EUR | -5.81 M EUR | -4.76 M EUR |
| 2006 | 10.46 M EUR | -18.78 M EUR | -17.39 M EUR |
| 2007 | 4.85 M EUR | -12.63 M EUR | -10.51 M EUR |
| 2008 | 3.17 M EUR | -13.8 M EUR | -12.58 M EUR |
| 2009 | 1.53 M EUR | -13 M EUR | -13.04 M EUR |
| 2010 | 4.47 M EUR | -9.03 M EUR | -9.25 M EUR |
| 2011 | 3.25 M EUR | -13.36 M EUR | -13.68 M EUR |
| 2012 | 26.81 M EUR | 18.87 M EUR | 16.01 M EUR |
| 2013 | 4.23 M EUR | -2.81 M EUR | -2.21 M EUR |
| 2014 | 3.46 M EUR | -12.04 M EUR | -9.1 M EUR |
| 2015 | 71,610 EUR | -35 M EUR | -28.21 M EUR |
| 2016 | 4.26 M EUR | -25.08 M EUR | -20.12 M EUR |
| 2017 | 5.81 M EUR | -15.84 M EUR | -12.09 M EUR |
| 2018 | 2.77 M EUR | -12.39 M EUR | -9.94 M EUR |
| 2019 | 8 M EUR | -9.36 M EUR | -7.02 M EUR |
| 2020 | 19.66 M EUR | 1.58 M EUR | 2.22 M EUR |
| 2021 | 7.13 M EUR | -22.08 M EUR | -21.79 M EUR |
| 2022 | 33.25 M EUR | 1.51 M EUR | -579,000 EUR |
| 2023e | 13.69 M EUR | -15.1 M EUR | -16.28 M EUR |
| 2024e | 20.4 M EUR | -12.07 M EUR | -14.3 M EUR |
| 2025e | 36.56 M EUR | -1.77 M EUR | -4.61 M EUR |
| 2026e | 48.16 M EUR | 8.25 M EUR | 1.24 M EUR |
| 2027e | 95.32 M EUR | 15.78 M EUR | 0 EUR |
| 2028e | 135.79 M EUR | 0 EUR | 0 EUR |
Paion stock margins DE000A0B65S3 · A0B65S
The Paion margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Paion. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Paion.
3 years
5 years
10 years
25 Years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the Paion's sales revenue. A higher gross margin percentage indicates that the Paion retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the Paion's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the Paion's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Paion's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Paion. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Paion's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
Paion Margin History
| Paion Gross margin | Paion Profit margin | Paion EBIT margin | Paion Profit margin |
|---|---|---|---|
| 2028e | 94.1 % | 0 % | 0 % |
| 2027e | 94.1 % | 16.56 % | 0 % |
| 2026e | 94.1 % | 17.12 % | 2.57 % |
| 2025e | 94.1 % | -4.83 % | -12.61 % |
| 2024e | 94.1 % | -59.16 % | -70.1 % |
| 2023e | 94.1 % | -110.33 % | -118.98 % |
| 2022 | 94.1 % | 4.53 % | -1.74 % |
| 2021 | 56.83 % | -309.73 % | -305.62 % |
| 2020 | 94.1 % | 8.02 % | 11.31 % |
| 2019 | 94.1 % | -116.95 % | -87.7 % |
| 2018 | 94.1 % | -447.86 % | -359.36 % |
| 2017 | 100 % | -272.65 % | -208.11 % |
| 2016 | 100 % | -588.56 % | -472.05 % |
| 2015 | 84.72 % | -48,868.88 % | -39,397.23 % |
| 2014 | 94.1 % | -348.54 % | -263.46 % |
| 2013 | 100 % | -66.43 % | -52.25 % |
| 2012 | 100 % | 70.38 % | 59.72 % |
| 2011 | 100 % | -411.08 % | -420.92 % |
| 2010 | 99.55 % | -202.01 % | -206.94 % |
| 2009 | 96.73 % | -849.67 % | -852.29 % |
| 2008 | 75.39 % | -435.33 % | -396.85 % |
| 2007 | 38.56 % | -260.41 % | -216.7 % |
| 2006 | 30.69 % | -179.54 % | -166.25 % |
| 2005 | 74.15 % | -30.9 % | -25.32 % |
| 2004 | 85.6 % | -0.53 % | 1.06 % |
| 2003 | 39.44 % | -1,550.7 % | -1,529.58 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2003 | 39.44 % | -1,550.7 % | -1,529.58 % |
| 2004 | 85.6 % | -0.53 % | 1.06 % |
| 2005 | 74.15 % | -30.9 % | -25.32 % |
| 2006 | 30.69 % | -179.54 % | -166.25 % |
| 2007 | 38.56 % | -260.41 % | -216.7 % |
| 2008 | 75.39 % | -435.33 % | -396.85 % |
| 2009 | 96.73 % | -849.67 % | -852.29 % |
| 2010 | 99.55 % | -202.01 % | -206.94 % |
| 2011 | 100 % | -411.08 % | -420.92 % |
| 2012 | 100 % | 70.38 % | 59.72 % |
| 2013 | 100 % | -66.43 % | -52.25 % |
| 2014 | 94.1 % | -348.54 % | -263.46 % |
| 2015 | 84.72 % | -48,868.88 % | -39,397.23 % |
| 2016 | 100 % | -588.56 % | -472.05 % |
| 2017 | 100 % | -272.65 % | -208.11 % |
| 2018 | 94.1 % | -447.86 % | -359.36 % |
| 2019 | 94.1 % | -116.95 % | -87.7 % |
| 2020 | 94.1 % | 8.02 % | 11.31 % |
| 2021 | 56.83 % | -309.73 % | -305.62 % |
| 2022 | 94.1 % | 4.53 % | -1.74 % |
| 2023e | 94.1 % | -110.33 % | -118.98 % |
| 2024e | 94.1 % | -59.16 % | -70.1 % |
| 2025e | 94.1 % | -4.83 % | -12.61 % |
| 2026e | 94.1 % | 17.12 % | 2.57 % |
| 2027e | 94.1 % | 16.56 % | 0 % |
| 2028e | 94.1 % | 0 % | 0 % |
Paion Aktienanalyse
What does Paion do?
Paion AG is a German pharmaceutical company based in Aachen. The company was founded in 2000 by four partners, including current CEO Dr. Wolfgang Söhngen. Since its founding, Paion has specialized in developing and marketing medications for sedation and anesthesia. In 2005, the company received approval for its first product, Remimazolam, a short-acting benzodiazepine that induces unconsciousness and is used in anesthesia and diagnostics. The medication has been on the market in Europe since 2020. Paion's business model is based on developing innovative medications that meet a high medical need and can succeed in the market. The company relies on intensive collaboration with its partners, including major pharmaceutical companies such as Mundipharma and Cosmo Pharmaceuticals. Paion develops its products until they are ready for the market and then transfers the marketing to its partners, allowing the company to fully focus on research and development of new medications. Over the years, Paion AG has specialized in various areas. In addition to anesthesia and sedation, the company has also made progress in neurology and oncology. Currently, Paion is developing a new medication for traumatic brain injury, which has already shown promising results in clinical trials. Another project involves the development of a treatment for lung cancer, which is also being tested in the clinical phase. Overall, Paion AG operates in various sectors and relies on close collaboration with its partners. The products offered by the company are all aimed at providing a high medical benefit and playing an important role in patient care. Paion is a dynamic company with a clear focus on innovation and growth. The health and well-being of patients are always a top priority. With its broad portfolio of innovative medications and successful collaboration with its partners, the company is well positioned to continue playing an important role in the market and expand its position as a leading provider of sedatives and anesthetics. Paion ist eines der beliebtesten Unternehmen auf Eulerpool.com.EBIT Details
Analyzing Paion's EBIT
Paion's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.
Year-to-Year Comparison
A yearly comparison of Paion's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.
Impact on Investments
Paion's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.
Interpreting EBIT Fluctuations
Fluctuations in Paion’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.
Frequently Asked Questions about Paion stock
What is EBIT?
EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company Paion.
How has the EBIT of Paion developed in recent years?
The EBIT of Paion has increased by -20.067% decreased compared to the previous year.
What does EBIT mean for investors?
EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.
Why is EBIT an important indicator for investors?
Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.
Why do EBIT values fluctuate?
EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.
What role does tax burden play in EBIT?
Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.
How is EBIT presented in the balance sheet of the company Paion?
The EBIT of Paion is listed in the income statement.
Can EBIT be used as a single indicator for evaluating a company?
EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.
Why is EBIT not equal to net profit?
The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.
How much dividend does Paion pay?
Over the past 12 months, Paion paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Paion is expected to pay a dividend of 0 EUR.
What is the dividend yield of Paion?
The current dividend yield of Paion is .
When does Paion pay dividends?
Paion pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Paion?
Paion paid dividends every year for the past 0 years.
What is the dividend of Paion?
For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.
In which sector is Paion located?
Paion is assigned to the 'Health' sector.
Wann musste ich die Aktien von Paion kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Paion from 11/22/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 11/22/2024.
When did Paion pay the last dividend?
The last dividend was paid out on 11/22/2024.
What was the dividend of Paion in the year 2023?
In the year 2023, Paion distributed 0 EUR as dividends.
In which currency does Paion pay out the dividend?
The dividends of Paion are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Paion stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Paion
Our stock analysis for Paion Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Paion Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
